A Prospective, Randomized Trial Assessing the Feasibility of an Advance Care Planning Intervention - Trial NCT06149312
Access comprehensive clinical trial information for NCT06149312 through Pure Global AI's free database. This phase not specified trial is sponsored by Institut de cancérologie Strasbourg Europe and is currently Not yet recruiting. The study focuses on Neoplasms. Target enrollment is 120 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Institut de cancérologie Strasbourg Europe
Timeline & Enrollment
N/A
Dec 11, 2023
Dec 11, 2024
Primary Outcome
Percentage of patients who write advance directives of living at 3 months
Summary
Advanced Cancer patients hospitalized in a Cancer center inpatient unit have a dismal
 prognosis. Palliative Care interventions have shown multiple benefit for those patients,
 regarding quality of life, symptom management, illness understanding and aggressiveness of
 care criteria. Although Advance Care planning (ACP) is part of usual Palliative Care,
 specific interventions dedicated to ACP are understudied.
 
 This study aims at showing that a simple and systematic Advance Care Planning intervention is
 likely to clarify the understanding of the goals of care by patients, to help with ACP
 documentation and and potentially to modify the trajectory of illness for patients during and
 after hospitalization.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06149312
Non-Device Trial